17 reports

Gastrointestinal General Physician Georgetown Public Hospital Corporation General Surgery Healthcare Health and Social Care Information Centre Joint Commission International Korea-U. S.

  • Incontinence Product
  • Market Size
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • C.R. Bard, Inc.

This condition is a symptom for individuals with chronic gastrointestinal conditions.

  • Incontinence Product
  • World
  • Market Size
  • Coloplast Group
  • ConvaTec Inc.

PRIOR TO THAT, SHE WAS A PRODUCT DEVELOPMENT ENGINEER AT AN NIH-FUNDED SBIR FIRM, WHERE SHE WORKED ON GASTROINTESTINAL BIOPSY AND ORTHOPEDIC DEVICES.

  • Incontinence Product
  • Asia
  • Europe
  • Forecast
  • Bayer AG
  • DRUG PROFILE: DARIFENACIN

M## receptors are involved in contraction of human bladder and gastrointestinal smooth muscle, saliva production, and iris sphincter function.

  • Incontinence Product
  • Pharmaceutical
  • United States
  • Market Size
  • Allergan plc
  • CELL THERAPY FOR ISCHEMIC HEART FAILURE, GASTROINTESTINAL DISORDERS AND UROLOGICAL DISEASES - DRUG PROFILE
  • URINARY INCONTINENCE - PIPELINE BY COOK MYOSITE INC, H1 2017
  • Incontinence Product
  • United States
  • World
  • Product Initiative
  • GTx, Inc.
  • Dialysis Device
  • Incontinence Product
  • Europe
  • Germany
  • Fresenius Group
  • Hospital
  • Incontinence Product
  • Japan
  • Market Size
  • EDAP TMS SA
  • URINARY INCONTINENCE - PIPELINE BY IPSEN SA, H2 2017
  • URINARY INCONTINENCE - PIPELINE BY INNOVACELL BIOTECHNOLOGIE AG, H2 2017

NA : Not Available Source: Global Markets Direct Regulatory Details Other Developmental Activities BTL-HS - DRUG PROFILE CELL THERAPY FOR ISCHEMIC HEART FAILURE, GASTROINTESTINAL DISORDERS AND UROLOGICAL DISEASES - DRUG PROFILE Cell Therapy for Ischemic Heart Failure,

  • Incontinence Product
  • Therapy
  • United States
  • Product Initiative
  • GTx, Inc.

(NYSE: GI), which offers physicians a broad portfolio of products to treat gastrointestinal conditions, for approximately $## million.

  • Incontinence Product
  • Urology Device
  • United States
  • Company
  • GlobalData's company

(NYSE: GI), which offers physicians a broad portfolio of products to treat gastrointestinal conditions, for approximately $## million.

  • Incontinence Product
  • Urology Device
  • United States
  • Company
  • Zynex, Inc.

(NYSE: GI), WHICH OFFERS PHYSICIANS A BROAD PORTFOLIO OF PRODUCTS TO TREAT GASTROINTESTINAL CONDITIONS, FOR APPROXIMATELY $## MILLION.

  • Incontinence Product
  • Medical Device
  • North America
  • United States
  • Medtronic, Inc.

Laborie Medical Technologies is a global provider of innovative medical devices for urological, pelvic health and gastrointestinal applications.

  • Dialysis Device
  • Incontinence Product
  • Canada
  • North America
  • Covalon Technologies Ltd.
  • Clinical Trial profile. 191 Trial Title
  • Prominent Drugs

Gastrointestinal Disorders and Urological Diseases ## mirabegron ER ## solifenacin succinate ## oxybutynin ## solifenacin ## Source: GlobalData' s Pharma eTrack Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2016 2016 trials are taken as of September 2016 Clinical T

  • Clinical Trial
  • Incontinence Product
  • Therapy
  • World
  • Astellas Pharma Inc.

THE MOST COMMON CANCERS WERE COLORECTAL, ENDOMETRIAL AND OTHER GASTROINTESTINAL CANCERS.

  • Health Services
  • Incontinence Product
  • North America
  • United States
  • AngioDynamics, Inc.

It has developed a unique proprietary biomimetic material technology for addressing the unmet needs for gastrointestinal reflux control (GERD).

  • Catheter
  • Clinical Trial
  • Incontinence Product
  • Urology Device
  • GlobalData's company
  • OVERACTIVE BLADDER - PIPELINE BY IPSEN SA, H1 2017
  • Indication Name

The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others.

  • Incontinence Product
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • OVERACTIVE BLADDER - PIPELINE BY HANMI PHARMACEUTICALS CO LTD, H2 2017
  • OVERACTIVE BLADDER - PIPELINE BY HYDRA BIOSCIENCES INC, H2 2017

Hanmi Pharma' s products are used in the treatment of cancer, depression, dementia, dermatology, diabetes, anti-inflammatory, cardiovascular, epilepsy, hepatitis, hypnotics, osteoarthritis, gastrointestinal, osteoporosis and others.

  • Incontinence Product
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative